Laurent Lässer
Novartis (Switzerland)(CH)
Research Areas
Angiogenesis and VEGF in Cancer, HER2/EGFR in Cancer Research, Click Chemistry and Applications
Most-Cited Works
- → New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis(2000)213 cited
- → New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis.(2000)23 cited